Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis

References

• Centers of Diseases Control and PreventionHealth Status and Determinants. Life Expectancy and Mortality2015 Available from: http://www.cdc.gov/nchs/data/hus/hus15.pdf#019Accessed May 1, 2016
   Google Scholar
• National Comprehensive Cancer Network [webpage on the Internet]Guidelines for Detection, Prevention, & Risk Reduction2017 Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed December 24, 2016
   Google Scholar
• HirschFRVarella-GarciaMBunnPAJrMolecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancerJ Clin Oncol200624315034504217075123
   PubMed Web of Science ®Google Scholar
• SharmaSVBellDWSettlemanJHaberDAEpidermal growth factor receptor mutations in lung cancerNat Rev Cancer20077316918117318210
   PubMed Web of Science ®Google Scholar
• MoroniMVeroneseSBenvenutiSGene copy number for epidermal growth factor receptor (EGFR) and clinical response to anti-EGFR treatment in colorectal cancer: a cohort studyLancet Oncology20056527928615863375
   PubMed Web of Science ®Google Scholar
• KarapetisCSKhambata-FordSJonkerDJK-ras mutations and benefit from cetuximab in advanced colorectal cancerN Engl J Med2008359171757176518946061
   PubMed Web of Science ®Google Scholar
• HolLde JongeVvan LeerdamMEScreening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopyEur J Cancer201046112059206620621736
   PubMed Web of Science ®Google Scholar
• GerlingerMRowanAJHorswellSIntratumor heterogeneity and branched evolution revealed by multiregion sequencingN Engl J Med20123661088389222397650
   PubMed Web of Science ®Google Scholar
• LeonSAShapiroBSklaroffDMYarosMJFree DNA in the serum of cancer patients and the effect of therapyCancer Res1977373646650837366
   PubMed Web of Science ®Google Scholar
• AnkerPMulcahyHChenXQStrounMDetection of circulating tumour DNA in the blood (plasma/serum) of cancer patientsCancer Metastasis Rev1999181657310505546
   PubMed Web of Science ®Google Scholar
• GormallyECabouxEVineisPHainautPCirculating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significanceMutat Res20076352–310511717257890
   PubMed Web of Science ®Google Scholar
• KoyanagiKMoriTO’DaySJMartinezSRWangHJHoonDSAssociation of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patientsCancer Res200666126111611716778184
   PubMed Web of Science ®Google Scholar
• MoriTO’DaySJUmataniNPredictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapyJ Clin Oncol200523369351935816361635
   PubMed Web of Science ®Google Scholar
• QiuMWangJXuYCirculating tumor DNA is effective for the detection of EGFR mutation in non-small cell lung cancer: a meta-analysisCancer Epidemiol Biomarkers Prev201524120621225339418
   PubMed Web of Science ®Google Scholar
• ThierryARMouliereFEl MessaoudiSClinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNANat Med201420443043524658074
   PubMed Web of Science ®Google Scholar
• BettegowdaCSausenMLearyRJDetection of circulating tumor DNA in early- and late-stage human malignanciesSci Transl Med20146224224ra24
   PubMed Web of Science ®Google Scholar
• DaneseEMinicozziAMBenatiMComparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancerPLoS One2015105e012641725946211
   PubMedGoogle Scholar
• KimSTChangWJJinLSungJSChoiYJKimYHCan serum be used for analyzing the KRAS mutation status in patients with advanced colorectal cancer?Cancer Res Treat201547479680325687873
   PubMedGoogle Scholar
• KopreskiMSBenkoFABorysDJKhanAMcGarrityTJGockeCDSomatic mutation screening: identification of individuals harboring K-ras mutations with the use of plasma DNAJ Natl Cancer Inst2000921191892310841827
   PubMedGoogle Scholar
• KuoYBChenJSFanCWLiYSChanECComparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancerClin Chim Acta201443328428924685572
   PubMed Web of Science ®Google Scholar
• LefebureBCharbonnierFDi FioreFPrognostic value of circulating mutant DNA in unresectable metastatic colorectal cancerAnn Surg2010251227528020010083
   PubMed Web of Science ®Google Scholar
• LinJKLinPCLinCHClinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumorsAnn Surg Oncol201421suppl 4S680S68624841357
   PubMed Web of Science ®Google Scholar
• LiuPLiangHXueLPotential clinical significance of plasma-based KRAS mutation analysis using the COLD-PCR/Taq-Man(®) -MGB probe genotyping methodExp Ther Med20124110911223060932
   PubMed Web of Science ®Google Scholar
• MiyanoSHanazawaKKitabatakeTFujisawaMKojimaKDetecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCRExp Ther Med20124579079423226727
   PubMed Web of Science ®Google Scholar
• MorganSRWhiteleyJDonaldEComparison of KRAS mutation assessment in tumor DNA and circulating free DNA in plasma and serum samplesClin Med Insights Pathol20125152222661904
   PubMedGoogle Scholar
• MulcahyHELyauteyJLederreyCPlasma DNA K-ras mutations in patients with gastrointestinal malignanciesAnn N Y Acad Sci2000906252810818591
   PubMed Web of Science ®Google Scholar
• PerroneFLampisABertanCCirculating free DNA in a screening program for early colorectal cancer detectionTumori2014100211512124852853
   PubMed Web of Science ®Google Scholar
• PuXPanZHuangYComparison of KRAS/BRAF mutations between primary tumors and serum in colorectal cancer: biological and clinical implicationsOncol Lett20135124925423255930
   PubMedGoogle Scholar
• RyanBMLefortFMcManusRA prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow upGut200352110110812477769
   PubMed Web of Science ®Google Scholar
• SakaiKTsurutaniJYamanakaTExtended RAS and BRAF mutation analysis using next-generation sequencingPLoS One2015105e012189125954997
   PubMedGoogle Scholar
• SefriouiDSarafan-VasseurNBeaussireLClinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancerDig Liver Dis2015471088489026160500
   PubMedGoogle Scholar
• SpindlerKLPallisgaardNAndersenRFBrandslundIJakobsenACirculating free DNA as biomarker and source for mutation detection in metastatic colorectal cancerPLoS One2015104e010824725875772
   PubMed Web of Science ®Google Scholar
• TalyVPekinDBenhaimLMultiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patientsClin Chem201359121722173123938455
   PubMed Web of Science ®Google Scholar
• XuJMLiuXJGeFJKRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancerJ Exp Clin Cancer Res20143310425491325
   PubMed Web of Science ®Google Scholar
• SorensonGDPribishDMValoneFHMemoliVABzikDJYaoSLSoluble normal and mutated DNA sequences from single-copy genes in human bloodCancer Epidemiol Biomarkers Prev19943167718118388
   PubMed Web of Science ®Google Scholar
• VasioukhinVAnkerPMauricePLyauteryJLederreyCStrounMPoint mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemiaBr J Haematol19948647747797918071
   PubMed Web of Science ®Google Scholar
• DeeksJJMacaskillPIrwigLThe performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJ Clin Epidemiol200558988289316085191
   PubMed Web of Science ®Google Scholar
• SwetsJAMeasuring the accuracy of diagnostic systemsScience19882404857128512933287615
   PubMed Web of Science ®Google Scholar
• DiehlFSchmidtKChotiMACirculating mutant DNA to assess tumor dynamicsNat Med200814998599018670422
   PubMed Web of Science ®Google Scholar
• NygaardADSpindlerKGPallisgaardNAndersonRFJakobsenALevels of cell-free DNA and plasma KRAS during treatment of advanced NSCLCOncol Rep20143196997424316734
   PubMedGoogle Scholar